Methodology, efficacy and safety of fecal microbiota transplantation in treating inflammatory bowel disease
Xiao Ding, Xiaozhong Yang, Honggang Wang
Medicine in Microecology · 2020
doi:10.1016/j.medmic.2020.100028 (opens in a new tab)
We email you when a new notice or a question about this paper appears.
Abstract
Fecal microbiota transplantation (FMT), as an emerging therapy, can be used to treat microbiota related diseases. Progresses in donor screening, washed microbiota preparation, microbiota delivery routes, clinical administrative strategies, and long-term safety are moving FMT forward. Increasing clinical studies, especially those randomized controlled trials about ulcerative colitis and pilot real-word studies about serious inflammatory bowel disease (IBD), have been conducted. This review presents the latest findings about the efficacy, safety and methodology of FMT in treating IBD.
Abstract licence: CC BY-NC-ND
References117
- 14.
- 40.
38 more references, whose wording the paper’s licence keeps private.
All 117 referencesReads
Read by people on this page
None yet.
Checked or read by AI through naulon
None yet.
A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.
Are you an author?
Is this your paper?
Claim it to add your note and be paid when agents cite it. Free.